IL17A and cystic fibrosis: Interestingly, TNF-α+IL-17 treatment elicited a 2-fold larger ΔISC-CFTR in non-CF epithelia than in ΔF508-CF epithelia exposed to CFTR modulators (Supplemental Figure 2A).